Yunnan Botanee Bio-Technology Group Co

Yunnan Botanee Bio-Technology Group Co PEG

PEG Ratio (Price/Earnings-to-Growth) of Yunnan Botanee Bio-Technology Group Co (300957.SZ) as of Nov 2, 2026.

PEG

-

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Yunnan Botanee Bio-Technology Group Co is 2026 - . PEG Ratio (Price/Earnings-to-Growth) of Yunnan Botanee Bio-Technology Group Co was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yunnan Botanee Bio-Technology Group Co Stock analysis

What does Yunnan Botanee Bio-Technology Group Co do? Yunnan Botanee Bio-Technology Group Co., Ltd. generates revenue through the research, development, manufacture, and sales of skin care products and services. The company's product portfolio includes creams, skin care lotions, facial masks, essences, lotions, and makeup items such as isolation creams, blemish balm (BB) creams, and makeup removers. Additionally, it offers medical device products like hyaluronic acid repairing biofilm and hyaluronic acid repairing dressings, designed for skin barrier protection post-minimally invasive surgery. Sales are driven by both offline and online channels, with the firm focusing on these distribution methods as key revenue streams. The company targets consumers seeking skincare solutions, particularly those requiring post-surgical skin care, through its medical device line. Its product range caters to a broad market segment, including daily skincare users and individuals needing specialized care for skin conditions. The firm's emphasis on both conventional skincare and medical-grade products allows it to address diverse consumer needs across multiple segments. Yunnan Botanee's revenue model relies on direct sales of its skincare and medical device products, with no mention of external partnerships or third-party branding. The company's focus on in-house R&D and manufacturing ensures control over product quality and pricing, supporting consistent revenue generation from its established customer base. Yunnan Botanee Bio-Technology Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yunnan Botanee Bio-Technology Group Co stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Yunnan Botanee Bio-Technology Group Co since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Yunnan Botanee Bio-Technology Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Yunnan Botanee Bio-Technology Group Co

All Key Metrics — Yunnan Botanee Bio-Technology Group Co